We were very pleased to see the recent article in the ARCHIVES by Ailani et al1 that compared doxycycline with other antibiotic regimens for inpatient therapy of community acquired pneumonia (CAP). Doxycycline is a drug that, justifiably in our opinion, is enjoying a resurgence.2 However, as Tice3 points out, few were expecting publications comparing doxycycline with other regimens for CAP.
Ditmanson L, Apgar D. Treatment for Community Acquired Pneumonia: More Support for Doxycycline. Arch Intern Med. 1999;159(15):1811-1817. doi: